Medicofarma Biotech Statistics

Total Valuation

WSE:MDB has a market cap or net worth of PLN 18.35 million. The enterprise value is 21.12 million.

Market Cap	18.35M
Enterprise Value	21.12M

Important Dates

The next estimated earnings date is Thursday, August 7, 2025.

Earnings Date	Aug 7, 2025
Ex-Dividend Date	n/a

Share Statistics

WSE:MDB has 67.98 million shares outstanding.

Current Share Class	67.98M
Shares Outstanding	67.98M
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	10.14M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	39.51
PB Ratio	2.98
P/TBV Ratio	3.03
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.04
EV / Sales	45.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.84, with a Debt / Equity ratio of 0.45.

Current Ratio	0.84
Quick Ratio	0.84
Debt / Equity	0.45
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-11.43

Financial Efficiency

Return on equity (ROE) is -37.35% and return on invested capital (ROIC) is -17.35%.

Return on Equity (ROE)	-37.35%
Return on Assets (ROA)	-11.51%
Return on Invested Capital (ROIC)	-17.35%
Return on Capital Employed (ROCE)	-28.48%
Revenue Per Employee	25,806
Profits Per Employee	-166,707
Employee Count	20
Asset Turnover	0.03
Inventory Turnover	989.10

Taxes

Income Tax	-22,736
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -38.91% in the last 52 weeks. The beta is 3.46, so WSE:MDB's price volatility has been higher than the market average.

Beta (5Y)	3.46
52-Week Price Change	-38.91%
50-Day Moving Average	0.28
200-Day Moving Average	0.36
Relative Strength Index (RSI)	46.36
Average Volume (20 Days)	19,990

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, WSE:MDB had revenue of PLN 464,514 and -3.00 million in losses. Loss per share was -0.04.

Revenue	464,514
Gross Profit	-1.09M
Operating Income	-2.77M
Pretax Income	-3.02M
Net Income	-3.00M
EBITDA	-1.33M
EBIT	-2.77M
Loss Per Share	-0.04

Full Income Statement

Balance Sheet

The company has 1,738 in cash and 2.77 million in debt, giving a net cash position of -2.77 million or -0.04 per share.

Cash & Cash Equivalents	1,738
Total Debt	2.77M
Net Cash	-2.77M
Net Cash Per Share	-0.04
Equity (Book Value)	6.15M
Book Value Per Share	0.09
Working Capital	-765,167

Full Balance Sheet

Cash Flow

Operating Cash Flow	-1.57M
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	-234.30%
Operating Margin	-597.21%
Pretax Margin	-650.89%
Profit Margin	n/a
EBITDA Margin	-285.96%
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

WSE:MDB does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-16.35%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on November 8, 2011. It was a reverse split with a ratio of 0.1.

Last Split Date	Nov 8, 2011
Split Type	Reverse
Split Ratio	0.1

Scores

WSE:MDB has an Altman Z-Score of 0.97 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	0.97
Piotroski F-Score	2